0000920465-18-000008.txt : 20180227 0000920465-18-000008.hdr.sgml : 20180227 20180227210048 ACCESSION NUMBER: 0000920465-18-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180223 FILED AS OF DATE: 20180227 DATE AS OF CHANGE: 20180227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARVER JENNIFER CENTRAL INDEX KEY: 0001663163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 18647824 MAIL ADDRESS: STREET 1: 725 NEWPORT STREET CITY: DENVER STATE: CO ZIP: 80220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_151978322910859.xml FORM 4 X0306 4 2018-02-23 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001663163 CARVER JENNIFER C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Operating Officer Common Stock 2018-02-23 4 P 0 1000 32.475 A 5500 D /s/ Ryan Murr, as attorney-in-fact for Jennifer A. Carver 2018-02-27